Why Global Blood Therapeutics Stock Is Vaulting Higher Today
Shares of rare-disease specialist Global Blood Therapeutics (NASDAQ: GBT) are rising sharply for the second day in a row. As of 12:38 p.m. ET, the drugmaker's stock was up by a healthy 38.4%.
Global Blood Therapeutics' shares have soared a whopping 104% so far this week. The biotech's stock has bolted higher in response to a report from Bloomberg News that multiple suitors are currently courting the drugmaker.
Image source: Getty Images.
Source Fool.com